FO
RPTP

FT Options’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

FT Options’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,568
Closed -$45K – 388
2015
Q4 		$45K Buy
+8,568
New +$49.7K 0.03% 155

FT Options's RPTP Position: Q1 2016 in Review

FT Options sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 8,568 shares — an estimated $45K sold.

FT Options first reported a position in RPTP in Q4 2015 and held it in 1 quarter. The position peaked at $45K in Q4 2015. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

  • FT Options reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • FT Options sold 8,568 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016, an estimated $45K.
  • FT Options first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 1 quarter.
  • FT Options's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $45K in Q4 2015.
  • 97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on FT Options's 13F filing for Q1 2016, filed 9 May 2016.